COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy
Novelli, Giuseppe, Biancolella, Michela, Mehrian-Shai, Ruty, Colona, Vita Luigi, Brito, Anderson F., Grubaugh, Nathan.D, Vasiliou, Vasilis, Luzzatto, Lucio, and Reichardt, Juergen K.V. (2021) COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy. Human Genomics, 15. 27.
|
PDF (Published Version)
- Published Version
Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
COVID-19 has engulfed the world and it will accompany us all for some time to come. Here, we review the current state at the milestone of 1 year into the pandemic, as declared by the WHO (World Health Organization). We review several aspects of the on-going pandemic, focusing first on two major topics: viral variants and the human genetic susceptibility to disease severity. We then consider recent and exciting new developments in therapeutics, such as monoclonal antibodies, and in prevention strategies, such as vaccines. We also briefly discuss how advances in basic science and in biotechnology, under the threat of a worldwide emergency, have accelerated to an unprecedented degree of the transition from the laboratory to clinical applications. While every day we acquire more and more tools to deal with the on-going pandemic, we are aware that the path will be arduous and it will require all of us being community-minded. In this respect, we lament past delays in timely full investigations, and we call for bypassing local politics in the interest of humankind on all continents.
Item ID: | 68002 |
---|---|
Item Type: | Article (Research - C1) |
ISSN: | 1479-7364 |
Copyright Information: | © The Author(s). 2021. Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License,which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you giveappropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate ifchanges were made. The images or other third party material in this article are included in the article's Creative Commonslicence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commonslicence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtainpermission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to thedata made available in this article, unless otherwise stated in a credit line to the data. |
Funders: | Regione Lazio (RL), Rome Foundation (RF) |
Projects and Grants: | RL Progetti di Gruppi di Ricerca 2020 A0375-2020-36663, RF Prot 317A/I, RF A028432 |
Date Deposited: | 15 Jul 2021 01:32 |
FoR Codes: | 32 BIOMEDICAL AND CLINICAL SCIENCES > 3201 Cardiovascular medicine and haematology > 320103 Respiratory diseases @ 100% |
SEO Codes: | 20 HEALTH > 2099 Other health > 209999 Other health not elsewhere classified @ 100% |
Downloads: |
Total: 781 Last 12 Months: 15 |
More Statistics |